1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019; 144: 1941-1953.
2. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5): 700-13. doi: 10.1158/1055-9965.EPI-13-1057. Epub 2014 Mar 11. PMID: 24618998; PMCID: PMC4019373.
3. Van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O'Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015; 52: 361-374.
4. Luo W, Fedda F, Lynch P, Tan D. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment. Front Pharmacol. 2018; 9: 1421.
5. van der Post RS, Vogelaar IP, Manders P, van der Kolk LE, Cats A, van Hest LP, Sijmons R, Aalfs CM, Ausems MG, Gómez García EB, Wagner A, Hes FJ, Arts N, Mensenkamp AR, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients with a Germline Mutation in CDH1. Gastroenterology 2015; 149: 897-906:
e19.
6. Ugai T., Sasamoto N., Lee H., Ando M.,
Song M., Tamimi R.M., Kawachi I., Campbell
P.T., Giovannucci E.L., Weiderpass E., et al.
Is early-onset cancer an emerging global
epidemic? Current evidence and future implications. Nat. Rev. Clin. Oncol. 2022; 19: 656-673. doi:
10.1038/s41571-022-00672-8.
7. Carneiro F. Familial and hereditary gastric cancer, an overview. Best Pract. Res. Clin. Gastroenterol. 2022; 58-59: 101800. doi: 10.1016/j.bpg.2022.101800.
8. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. Nature. 1998; 392: 402-405.
9. Gjyshi O, Vashi P, Seewald L, Kohan M, Abboud E, Fowler E, Suppiah R, Halabi H. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series. World J Surg Oncol. 2018 Jul 14; 16(1): 143. doi: 10. 1186/s12957-018-1415-5. PMID: 30007404; PMCID: PMC6046101.
10. de Assumpção PB, de Assumpção PP, Moreira FC, Ribeiro-Dos-Santos Â, Vidal AF, Magalhães L, Khayat AS, Ribeiro-Dos-Santos AM, Cavalcante GC, Pereira AL, Medeiros I, de Souza SJ, Burbano RMR, de Souza JES, Dos Santos SEB. Incidence of Hereditary Gastric Cancer May Be Much Higher than Reported. Cancers (Basel). 2022 Dec 12; 14(24): 6125. doi: 10.3390/cancers14246125. PMID: 36551612; PMCID: PMC9776697.
